Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards
Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial.
Society of Interventional Radiology seeks AMA resolution urging payments on high-cost disposables
"The number of non-facility services reimbursed at less than direct costs grew 50% since 2024. The number of services under the MPFS for which reimbursement does not even cover cost likely is much higher than 300 services," the proposed AMA resolution states.
Medtronic drug-coated balloon gains multiple new approvals
The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA.
SCAI wants lead-free cath labs and a better work-life balance for cardiologists
"The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview.
Cardiologist shares positive first-in-human data on TriCares TTVR device
The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure.

Cardiologists share late-breaking TAVR data on first day of SCAI 2025

New TAVR data on SAPT vs. DAPT and prosthesis-patient mismatch among women were some of the many highlights of the conference's opening day.

A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis

The FDA has approved the balloon-expandable Sapien 3 TAVR platform from Edwards Lifesciences for treating asymptomatic severe aortic stenosis. This is the first time the agency has approved any TAVR technology to be used in asymptomatic patients.

OmniaSecure defibrillation lead for placement within a patient’s right ventricle

Medtronic receives FDA approval for smallest defibrillation lead of its kind

Medtronic emphasized that this device should be especially valuable when treating younger patients or those with a small anatomy.

AI healthcare doctor surgery procedure artificial intelligence

AI helps cardiologists terminate AFib for good with ablation

Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care.

doctor patient discharge after heart surgery

Same-day discharge after cardiac ablation: Cardiologists share recommendations

Same-day discharge won't always be a great fit after cardiac ablation, of course, but it has been associated with considerable patient satisfaction as well as improved efficiency and substantial cost savings. The Heart Rhythm Society and American College of Cardiology have shared a new scientific statement on the subject.

Field Medical FieldForce Ablation pulsed field ablation

PFA startup founded by industry veteran to share first-in-human data at Heart Rhythm 2025

Field Medical, founded in 2022 by Steven Mickelsen, MD, is set to make a significant splash at the Heart Rhythm Society's annual meeting in San Diego. The company also just raised $40 million in financing.

Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns

The devices are being recalled and discontinued after the FDA shared a series of concerns. This is a Class I recall, meaning using this system could result in serious injuries or death.

Underweight TAVR patients face higher mortality risk—obesity makes no significant impact

Reviewing data from more than 6,000 patients, researchers found little evidence of the "obesity paradox" observed elsewhere. Underweight TAVR patients, however, may face some significant long-term risks.

Interventional Cardiology

Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards

Society of Interventional Radiology seeks AMA resolution urging payments on high-cost disposables

Medtronic drug-coated balloon gains multiple new approvals

SCAI wants lead-free cath labs and a better work-life balance for cardiologists

Cardiologist shares positive first-in-human data on TriCares TTVR device